Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
PTSD, Post-Traumatic Stress Disorder, was once not even considered as a medical disorder by physicians. However, now through plenty of clinical studies, trials, and medical research, PTSD is now known to be a serious and legitimate medical disorder that needs appropriate medical treatment.
With so many options out there, how can you know what the right treatment ever is? Therapy and counseling was a common treatment method in the past, but proved throughout history to not be a viable option. This was followed by the use of anti-anxiety meds to try and calm PTSD episodes, but these were only slightly successful as it didn’t increase the overall quality of life for those with PTSD.
Examples of FDA approved medications include:
Examples of non-FDA approved medications include:
A lot of these treatments proved to be unsuccessful, but physicians could not figure out why up until in 2012, when they discovered a crucial missing piece of the puzzle.
While conducting research on the brain of PTSD victims, one researcher found tiny scars on the surface in a distinct pattern. This discovery was the first to find that PTSD could be physically identified in the brain—that the trauma suffered by a patient can physically alter the brain. Due to this, the research of treatment options, medication specifically, for PTSD has become incredibly important in the medical community. The Institute for Advanced Medical Research is proud to be a member of a medical community that takes part in the advancement of healthcare for those going through PTSD.
The Institute for Advanced Medical Research studies advancements in treatments and medications for PTSD. Participating in a medical study is cost-free and confidential. The clinic is not affiliated with the DOD or VA. If you or a loved one is going through PTSD, contact us for information or treatment options at 770-817-9200.
You Might Also Enjoy...
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Pain can be depressing, and depression creates and exacerbates pain. This cycle can be a dangerous one. In fact, people afflicted by chronic pain are three times more likely to develop psychiatric disorders (most often anxiety or mood disorders).
Depression is a mental disorder that both men and women struggle with. However, in the case of men, the disorder can look very differently that it looks in women.
Anyone that has had Chickenpox, even if it was all the way back in childhood, now lives with the risk of experiencing Shingles when they enter their later years. And what does that have to do with Fibromyalgia?!
If you or a loved one are still struggling with depression even on medication, you are not the only one!
Fibromyalgia is painful, difficult to diagnose and has limited treatment options. But there are always new drugs being developed! #Fibro #FibroATL #FibroAlpharetta #FibroOptions